These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6594527)

  • 21. [Importance and trends of prenatal diagnostics].
    Sandig KR; Mücke J; Theile H
    Z Gesamte Inn Med; 1981 Jun; 36(11):352-6. PubMed ID: 7303761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Early amniocentesis: answers for the practitioner].
    Chenevart P; Nguyen The H; Pescia G; De Grandi P
    Rev Med Suisse Romande; 1981 Nov; 101(11):887-90. PubMed ID: 7323565
    [No Abstract]   [Full Text] [Related]  

  • 23. The effectiveness of prenatal serum biomarker screening for neural tube defects in second trimester pregnant women: a meta-analysis.
    Wang ZP; Li H; Hao LZ; Zhao ZT
    Prenat Diagn; 2009 Oct; 29(10):960-5. PubMed ID: 19609892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Miscarriage risk from amniocentesis performed for abnormal maternal serum screening.
    Towner D; Currier RJ; Lorey FW; Cunningham GC; Greve LC
    Am J Obstet Gynecol; 2007 Jun; 196(6):608.e1-5; discussion 608.e5. PubMed ID: 17547917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of congenital anomalies at birth among offspring of women at risk for a genetic disorder and with a normal second-trimester ultrasound.
    Lemyre E; Infante-Rivard C; Dallaire L
    Teratology; 1999 Oct; 60(4):240-4. PubMed ID: 10508977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fetoplacental and fetoamniotic chromosomal discrepancies in prenatally detected mosaic trisomy 9.
    Chen CP; Chern SR; Town DD; Wang W; Liao YW
    Prenat Diagn; 2003 Dec; 23(12):1019-21. PubMed ID: 14663842
    [No Abstract]   [Full Text] [Related]  

  • 27. Amniocentesis in the second trimester.
    Med Lett Drugs Ther; 1978 Oct; 20(21):93-4. PubMed ID: 151773
    [No Abstract]   [Full Text] [Related]  

  • 28. [Genetic counseling and prenatal diagnosis in families with neural tube defects].
    Mikiel-Kostyra K
    Probl Med Wieku Rozwoj; 1983; 12():244-62. PubMed ID: 6674977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal serum screening.
    Lofsky S
    CMAJ; 1999 Apr; 160(8):1125-6. PubMed ID: 10234332
    [No Abstract]   [Full Text] [Related]  

  • 30. Prenatal screening for neural tube defects.
    Rajesh R; Thomas SV
    Natl Med J India; 2001; 14(6):343-6. PubMed ID: 11804365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy loss rates after midtrimester amniocentesis.
    Eddleman KA; Malone FD; Sullivan L; Dukes K; Berkowitz RL; Kharbutli Y; Porter TF; Luthy DA; Comstock CH; Saade GR; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME
    Obstet Gynecol; 2006 Nov; 108(5):1067-72. PubMed ID: 17077226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Amniocentesis at 12 or 15 weeks?].
    Muller F; Tachdjian G
    Contracept Fertil Sex; 1999 Apr; 27(4):277-8. PubMed ID: 10349770
    [No Abstract]   [Full Text] [Related]  

  • 33. [Serum analysis in pregnant women. Mass screening is an effective way to discover chromosome aberrations--arguments for and against].
    Kristoffersson U; Nørgaard-Pedersen B
    Lakartidningen; 1995 Mar; 92(12):1205-6, 1211-2. PubMed ID: 7535873
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prenatal diagnosis: indications, methods, complications (author's transl)].
    Cachro A
    Przegl Lek; 1980; 37(12):803-6. PubMed ID: 7208968
    [No Abstract]   [Full Text] [Related]  

  • 35. Maternal diabetes and neural tube defects: prenatal diagnosis of lumbosacral myelomeningocele, ventriculomegaly, Arnold-Chiari malformation and foot deformities in a pregnancy with poor maternal metabolic control, and review of the literature.
    Chen CP
    Genet Couns; 2005; 16(3):313-6. PubMed ID: 16259331
    [No Abstract]   [Full Text] [Related]  

  • 36. Antenatal diagnosis of neural tube defects--simple cytological examination.
    Phadke MA; Pote PD; Khedkar VA; Kate SL; Ranade LS; Saraph AA; Tembe MV
    Indian Pediatr; 1987 Jul; 24(7):557-9. PubMed ID: 3692585
    [No Abstract]   [Full Text] [Related]  

  • 37. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.
    Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ
    Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)].
    Thix J
    Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):25-9. PubMed ID: 9303823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prenatal diagnosis].
    Miny P; Tercanli S; Gänshirt D; Holzgreve W
    Ther Umsch; 1995 Dec; 52(12):792-800. PubMed ID: 8539649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.